Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Leptin Infusion and Obesity in Mouse Cause Alterations in the Hypothalamic Melanocortin System

Leptin Infusion and Obesity in Mouse Cause Alterations in the Hypothalamic Melanocortin System The objectives of this study were to identify potential alterations in gene expression of melanocortin‐4 receptor (MC4‐R), proopiomelanocortin (POMC), and Agouti‐related protein (AgRP) in mouse hypothalamus under a chronic peripheral infusion of leptin or at early (8 weeks) and advanced (16 weeks) phases of diet‐induced obesity. Control or diet‐induced obesity mice (8 or 16 weeks of high‐fat diet) were either treated or not treated with leptin. Metabolic features were analyzed and expression of the genes of interest was measured by quantitative reverse transcriptase‐PCR (RT‐qPCR) and western blot. We reported that in control mice, but not in obese mice, leptin infusion induced an increase in POMC mRNA level as well as in MC4‐R mRNA level suggesting that leptin could act directly and/or through α‐melanocyte‐stimulating hormone (α‐MSH). This hypothesis was reinforced after in vitro studies, using the mouse hypothalamic GT1‐7 cell line, since both leptin and Norleucine4, D‐Phenylalanine7‐α‐MSH (NDP‐α‐MSH) treatments increased MC4‐R expression. After 8 weeks of high‐fat diet, nondiabetic obese mice became resistant to the central action of leptin and their hypothalamic content of POMC and AgRP mRNA were decreased without modification of MC4‐R mRNA level. After 16 weeks of high‐fat diet, mice exhibited more severe metabolic disorders with type 2 diabetes. Moreover, hypothalamic expression of MC4‐R was highly increased. In conclusion, several alterations of the melanocortin system were found in obese mice that are probably consecutive to their central resistance to leptin. Moreover, when the metabolic status is highly degraded (with all characteristics of a type 2 diabetes), other regulatory mechanisms (independent of leptin) can also take place. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obesity Wiley

Leptin Infusion and Obesity in Mouse Cause Alterations in the Hypothalamic Melanocortin System

Download PDF
7 pages

Loading next page...
 
/lp/wiley/leptin-infusion-and-obesity-in-mouse-cause-alterations-in-the-1siGw3uUJT

References (38)

Publisher
Wiley
Copyright
Copyright © 2008 Wiley Subscription Services
ISSN
1930-7381
eISSN
1930-739X
DOI
10.1038/oby.2008.303
pmid
18551122
Publisher site
See Article on Publisher Site

Abstract

The objectives of this study were to identify potential alterations in gene expression of melanocortin‐4 receptor (MC4‐R), proopiomelanocortin (POMC), and Agouti‐related protein (AgRP) in mouse hypothalamus under a chronic peripheral infusion of leptin or at early (8 weeks) and advanced (16 weeks) phases of diet‐induced obesity. Control or diet‐induced obesity mice (8 or 16 weeks of high‐fat diet) were either treated or not treated with leptin. Metabolic features were analyzed and expression of the genes of interest was measured by quantitative reverse transcriptase‐PCR (RT‐qPCR) and western blot. We reported that in control mice, but not in obese mice, leptin infusion induced an increase in POMC mRNA level as well as in MC4‐R mRNA level suggesting that leptin could act directly and/or through α‐melanocyte‐stimulating hormone (α‐MSH). This hypothesis was reinforced after in vitro studies, using the mouse hypothalamic GT1‐7 cell line, since both leptin and Norleucine4, D‐Phenylalanine7‐α‐MSH (NDP‐α‐MSH) treatments increased MC4‐R expression. After 8 weeks of high‐fat diet, nondiabetic obese mice became resistant to the central action of leptin and their hypothalamic content of POMC and AgRP mRNA were decreased without modification of MC4‐R mRNA level. After 16 weeks of high‐fat diet, mice exhibited more severe metabolic disorders with type 2 diabetes. Moreover, hypothalamic expression of MC4‐R was highly increased. In conclusion, several alterations of the melanocortin system were found in obese mice that are probably consecutive to their central resistance to leptin. Moreover, when the metabolic status is highly degraded (with all characteristics of a type 2 diabetes), other regulatory mechanisms (independent of leptin) can also take place.

Journal

Obesity – Wiley

Published: Jan 1, 2008

There are no references for this article.